BIOCRYST PHARMACEUTICALS INC ($BCRX)
Filing Information
| Accession Number | 0000882796-26-000021 |
|---|---|
| Form Type | 4 |
| Filing Date | May 15, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
187,500
Total Value
$911,250.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | May 13, 2026 | Exercise/Conversion | 62,500 | $5.04 | $315,000.00 | 463,203 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 13, 2026 | Sale | 62,500 | $9.54 | $596,250.00 | 400,703 | Direct | โ | View Details | |
Chief Legal Officer | Emp. Stock Option (Right to Buy) | Derivative | May 13, 2026 | Exercise/Conversion | 62,500 | $0.00 | $0.00 | 0 | Direct | โ | View Details |